Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Kumar, Hemant ^a   Choi, Dong Kug ^a  

^a Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBONATE DEHYDRATASE; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 4; CYTOCHROME C; CYTOCHROME C1; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON SULFUR PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; OXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BNIP3; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SODIUM PROTON EXCHANGE PROTEIN 1; SUPEROXIDE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; VASCULOTROPIN; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE; OXYGEN; TRANSCRIPTION FACTOR;

ADAPTATION; ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; CARTILAGE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CITRIC ACID CYCLE; CRYSTAL STRUCTURE; EMBRYONIC STEM CELL; ENCHONDRAL OSSIFICATION; ENDURANCE; ENDURANCE TRAINING; ENZYME ACTIVE SITE; ENZYME DEGRADATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GLYCOLYSIS; HUMAN; HYPOGLYCEMIA; HYPOXIA; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN TENSION; PH; PHYSIOLOGICAL ADAPTATION; RESISTANCE TRAINING; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TROPHOBLAST; UBIQUITINATION; ANIMAL; CHEMISTRY; EXERCISE; HOMEOSTASIS; INFLAMMATION; ISCHEMIA; METABOLISM; MITOCHONDRION; MOUSE; NEOPLASM; OXYGEN CONSUMPTION; PATHOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; EXERCISE; HOMEOSTASIS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; ISCHEMIA; MICE; MITOCHONDRIA; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; PROLYL HYDROXYLASES; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 84944254470     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/584758     Document Type: Review

References (147)

1. H. Tian, S. L. McKnight, and D. W. Russell, "Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells," Genes&Development, vol. 11, no. 1, pp. 72-82, 1997
2. M. Ema, S. Taya, N. Yokotani, K. Sogawa, Y. Matsuda, and Y. Fujii-Kuriyama, "A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 regulates the VEGF expression and is potentially involved in lung and vascular development," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4273-4278, 1997
3. Y. Z. Gu, S. M. Moran, J. B. Hogenesch, L. Wartman, and C. A. Bradfield, "Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha," Gene Expression, vol. 7, no. 3, pp. 205-213, 1998
4. G. L. Semenza, "Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1," Annual Review of Cell and Developmental Biology, vol. 15, pp. 551-578, 1999
5. L. E. Eric Huang, E. A. Pete, M. Schau, J. Milligan, and J. Gu, "Leu-574 of HIF-1 is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway," The Journal of Biological Chemistry, vol. 277, no. 44, pp. 41750-41755, 2002
6. Y. Kageyama,M. Koshiji,K. K. W. To, Y.-M. Tian, P. J. Ratcliffe, and L. E. Huang, "Leu-574 of human HIF-1 is a molecular determinant of prolyl hydroxylation," The FASEB Journal, vol. 18, no. 9, pp. 1028-1030, 2004
7. N. Masson, C. Willam, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe, "Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation," The EMBO Journal, vol. 20, no. 18, pp. 5197-5206, 2001
8. M. C. Simon and B. Keith, "The role of oxygen availability in embryonic development and stem cell function," Nature Reviews Molecular Cell Biology, vol. 9, no. 4, pp. 285-296, 2008
9. P. J. Kallio, K. Okamoto, S. O'Brien et al., "Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha," The EMBO Journal, vol. 17, no. 22, pp. 6573-6586, 1998
10. C. W. Pugh, J. F. O'Rourke, M. Nagao, J. M. Gleadle, and P. J. Ratcliffe, "Activation of hypoxia-inducible factor-1; Definition of regulatory domains within the subunit," The Journal of Biological Chemistry, vol. 272, no. 17, pp. 11205-11214, 1997
11. R. Fukuda, H. Zhang, J. W. Kim, L. Shimoda, C. V. Dang, and G. Semenza, "HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells," Cell, vol. 129, no. 1, pp. 111-122, 2007
12. C. Warnecke, Z. Zaborowska, J. Kurreck et al., "Differentiating the functional role of hypoxia-inducible factor (HIF)-1 and HIF-2 (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2 target gene in Hep3B and Kelly cells," The FASEB Journal, vol. 18, no. 12, pp. 1462-1464, 2004
13. C.-J. Hu, L.-Y. Wang, L. A. Chodosh, B. Keith, and M. C. Simon, "Differential Roles of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in Hypoxic Gene Regulation," Molecular and Cellular Biology, vol. 23, no. 24, pp. 9361-9374, 2003
14. R. R. Raval, K. W. Lau, M. G. B. Tran et al., "Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma," Molecular and Cellular Biology, vol. 25, no. 13, pp. 5675-5686, 2005
15. G. P. Elvidge, L. Glenny, R. J. Appelhoff, P. J. Ratcliffe, J. Ragoussis, and J. M. Gleadle, "Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1, HIF-2, and other pathways,"The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15215-15226, 2006
16. M. Heidbreder, F. Fröhlich, O. Jöhren, A. Dendorfer, F. Qadri, and P. Dominiak, "Hypoxia rapidly activatesHIF-3alphamRNA expression," The FASEB Journal, vol. 17, no. 11, pp. 1541-1543, 2003
17. P. Zhang, L. Lu, Q. Yao et al., "Molecular, functional, and gene expression analysis of zebrafish hypoxia-inducible factor-3alpha," The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 303, no. 11, pp. R1165-R1174, 2012
18. Y. Makino, A. Kanopka, W. J. Wilson, H. Tanaka, and L. Poellinger, "Inhibitory PAS domain protein (IPAS) is a hypoxiainducible splicing variant of the hypoxia-inducible factor-3 locus," The Journal of Biological Chemistry, vol. 277, no. 36, pp. 32405-32408, 2002
19. L. Holmquist-Mengelbier, E. Fredlund, T. Löfstedt et al., "Recruitment of HIF-1 and HIF-2 to common target genes is differentially regulated in neuroblastoma: HIF-2 promotes an aggressive phenotype," Cancer Cell, vol. 10, no. 5, pp. 413-423, 2006
20. M. Y. Koh, R. Lemos Jr., X. Liu, and G. Powis, "The hypoxia-associated factor switches cells from HIF-1-to HIF-2-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion," Cancer Research, vol. 71, no. 11, pp. 4015-4027, 2011
21. P. Jaakkola, D. R. Mole, Y.-M. Tian et al., "Targeting of HIF- to the vonHippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation," Science, vol. 292, no. 5516, pp. 468-472, 2001
22. M. Ivan, K. Kondo, H. Yang et al., "HIF targeted for VHLmediated destruction by proline hydroxylation: implications for O2 sensing," Science, vol. 292, no. 5516, pp. 464-468, 2001
23. L. E. Huang, J. Gu, M. Schau, and H. F. Bunn, "Regulation of hypoxia-inducible factor 1 is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 14, pp. 7987-7992, 1998
24. A. C. R. Epstein, J. M. Gleadle, L. A. McNeill et al., "C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation," Cell, vol. 107, no. 1, pp. 43-54, 2001
25. E. Berra, E. Benizri, A. Ginouvès, V. Volmat, D. Roux, and J. Pouysségur, "HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1 in normoxia," The EMBO Journal, vol. 22, no. 16, pp. 4082-4090, 2003
26. K. Lee,H. Zhang,D. Z. Qian, S. Rey, J. O. Liu, and G. L. Semenza, "Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization," Proceedings of theNationalAcademy of Sciences of the United States of America, vol. 106, no. 42, pp. 17910-17915, 2009
27. R. Chowdhury, M. A. McDonough, J. Mecinovíc et al., "Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases," Structure, vol. 17, no. 7, pp. 981-989, 2009
28. M. E. Lieb, K. Menzies, M. C. Moschella, R. Ni, and M. B. Taubman, "Mammalian EGLN genes have distinct patterns of mRNA expression and regulation," Biochemistry and Cell Biology, vol. 80, no. 4, pp. 421-426, 2002
29. J. Aragonés, M. Schneider, K. van Geyte et al., "Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism," Nature Genetics, vol. 40, no. 2, pp. 170-180, 2008
30. M. Schneider, K. van Geyte, P. Fraisl et al., "Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury," Gastroenterology, vol. 138, no. 3, pp. 1143. e2-1154. e2, 2010
31. K. Takeda, V. C. Ho, H. Takeda, L.-J. Duan, A. Nagy, and G.-H. Fong, "Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2," Molecular and Cellular Biology, vol. 26, no. 22, pp. 8336-8346, 2006
32. K. Takeda, A. Cowan, and G.-H. Fong, "Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system," Circulation, vol. 116, no. 7, pp. 774-781, 2007
33. Y. A. Minamishima, J. Moslehi, N. Bardeesy, D. Cullen, R. T. Bronson, and W. G. Kaelin Jr., "Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure," Blood, vol. 111, no. 6, pp. 3236-3244, 2008
34. T. Bishop, D. Gallagher, A. Pascual et al., "Abnormal sympathoadrenal development and systemic hypotension in PHD3/ mice," Molecular and Cellular Biology, vol. 28, no. 10, pp. 3386-3400, 2008
35. B. Oriowo, M. Thirunavukkarasu, V. Selvaraju et al., "Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction," Current Pharmaceutical Design, vol. 20, no. 9, pp. 1305-1310, 2014
36. B. M. Babior, "The NADPH oxidase of endothelial cells," IUBMB Life, vol. 50, no. 4-5, pp. 267-269, 2000
37. B. M. Babior, J. D. Lambeth, and W. Nauseef, "The neutrophil NADPH oxidase," Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 342-344, 2002
38. M. J. Coon, X. Ding, S. J. Pernecky, and A. D. N. Vaz, "Cytochrome P450: progress and predictions," The FASEB Journal, vol. 6, no. 2, pp. 669-673, 1992
39. Y. Yokoyama, J. S. Beckman, T. K. Beckman et al., "Circulating xanthine oxidase: potential mediator of ischemic injury," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 258, no. 4, pp. G564-G570, 1990
40. J. F. Turrens, "Superoxide production by the mitochondrial respiratory chain," Bioscience Reports, vol. 17, no. 1, pp. 3-8, 1997
41. M. L. Genova, B. Ventura, G. Giuliano et al., "The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2," FEBS Letters, vol. 505, no. 3, pp. 364-368, 2001
42. S. Alvarez, L. B. Valdez, T. Zaobornyj, and A. Boveris, "Oxygen dependence of mitochondrial nitric oxide synthase activity," Biochemical and Biophysical Research Communications, vol. 305, no. 3, pp. 771-775, 2003
43. G. B. Waypa and P. T. Schumacker, "O2 sensing in hypoxic pulmonary vasoconstriction: themitochondrial door re-opens," Respiratory Physiology and Neurobiology, vol. 132, no. 1, pp. 81-91, 2002
44. P. T. Schumacker, "Hypoxia, anoxia, and O2 sensing: the search continues," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 283, no. 5, pp. L918-L921, 2002
45. N. S. Chandel, E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon, and P. T. Schumacker, "Mitochondrial reactive oxygen species trigger hypoxia-induced transcription," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11715-11720, 1998
46. C. Schroedl, D. S. McClintock, G. R. S. Budinger, and N. S. Chandel, "Hypoxic but not anoxic stabilization of HIF-1 requires mitochondrial reactive oxygen species," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 283, no. 5, pp. L922-L931, 2002
47. F. H. Agani, P. Pichiule, J. C. Chavez, and J. C. LaManna, "The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia," The Journal of Biological Chemistry, vol. 275, no. 46, pp. 35863-35867, 2000
48. H. Kumar, H. W. Lim, S. V. More et al., "The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism," International Journal of Molecular Sciences, vol. 13, no. 8, pp. 10478-10504, 2012
49. L. D. Lukyanova, "Mitochondrial signaling in hypoxia," Open Journal of Endocrine and Metabolic Diseases, vol. 3, no. 2, pp. 20-32, 2013
50. K. D. Mansfield, R. D. Guzy, Y. Pan et al., "Mitochondrial dysfunction resulting fromloss of cytochrome c impairs cellular oxygen sensing and hypoxicHIF- Activation," CellMetabolism, vol. 1, no. 6, pp. 393-399, 2005
51. R. D. Guzy, B. Hoyos, E. Robin et al., "Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing," Cell Metabolism, vol. 1, no. 6, pp. 401-408, 2005
52. N. S. Chandel, D. S. McClintock, C. E. Feliciano et al., "Reactive oxygen species generated at mitochondrial Complex III stabilize hypoxia-inducible factor-1 during hypoxia: a mechanism of O2 sensing," The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25130-25138, 2000
53. E. L. Bell, T. A. Klimova, J. Eisenbart et al., "The site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production," The Journal of Cell Biology, vol. 177, no. 6, pp. 1029-1036, 2007
54. D. E. Richard, E. Berra, and J. Pouyssegur, "Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 in vascular smooth muscle cells," The Journal of Biological Chemistry, vol. 275, no. 35, pp. 26765-26771, 2000
55. L. E. Kotch, N. V. Iyer, E. Laughner, and G. L. Semenza, "Defective vascularization of HIF-1-null embryos is not associated with VEGF deficiency but with mesenchymal cell death," Developmental Biology, vol. 209, no. 2, pp. 254-267, 1999
56. H. Tian, R. E. Hammer, A. M. Matsumoto, D. W. Russell, and S. L. McKnight, "The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development," Genes and Development, vol. 12, no. 21, pp. 3320-3324, 1998
57. D. M. Stroka, T. Burkhardt, I. Desbaillets et al., "HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia," The FASEB Journal, vol. 15, no. 13, pp. 2445-2453, 2001
58. J. Peng, L. Zhang, L. Drysdale, and G.-H. Fong, "The transcription factor EPAS-1/hypoxia-inducible factor 2 plays an important role in vascular remodeling," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8386-8391, 2000
59. K. Brusselmans, F. Bono, P. Maxwell et al., "Hypoxia-inducible factor-2 (HIF-2) is involved in the apoptotic response to hypoglycemia but not to hypoxia," The Journal of Biological Chemistry, vol. 276, no. 42, pp. 39192-39196, 2001
60. D. Chilov, T. Hofer, C. Bauer, R. H. Wenger, and M. Gassmann, "Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain," The FASEB Journal, vol. 15, no. 14, pp. 2613-2622, 2001
61. H. H. Marti, D. M. Katschinski, K. F. Wagner, L. Schäffer, B. Stier, and R. H. Wenger, "Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages ofmouse spermiogenesis," Molecular Endocrinology, vol. 16, no. 2, pp. 234-243, 2002
62. D. Lukashev, C. Caldwell, A. Ohta, P. Chen, and M. Sitkovsky, "Differential Regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1alpha in activated T lymphocytes," The Journal of Biological Chemistry, vol. 276, no. 52, pp. 48754-48763, 2001
63. D. M. Katschinski, L. Le, D. Heinrich et al., "Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity," Journal of Biological Chemistry, vol. 277, no. 11, pp. 9262-9267, 2002
64. R. Lall, S. Ganapathy, M. Yang et al., "Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response," Cell Death and Differentiation, vol. 21, no. 5, pp. 836-844, 2014
65. S. Carrera, J. Senra, M. I. Acosta et al., "The role of the HIF-1 transcription factor in increased cell division at physiological oxygen tensions," PLoS ONE, vol. 9, no. 5, Article ID e97938, 2014
66. C.-H. Kim, Y.-S. Cho, Y.-S. Chun, J.-W. Park, and M.-S. Kim, "Early expression ofmyocardialHIF-1 in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway," Circulation Research, vol. 90, no. 2, pp. e25-e33, 2002
67. N. V. Iyer, L. E. Kotch, F. Agani et al., "Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1," Genes and Development, vol. 12, no. 2, pp. 149-162, 1998
68. H. E. Ryan, J. Lo, and R. S. Johnson, "HIF-1 is required for solid tumor formation and embryonic vascularization," The EMBO Journal, vol. 17, no. 11, pp. 3005-3015, 1998
69. E. J. Folco, G. K. Sukhova, T. Quillard, and P. Libby, "Moderate hypoxia potentiates interleukin-1beta production in activated human macrophages," Circulation Research, vol. 115, no. 10, pp. 875-883, 2014
70. A. Y. Yu, L. A. Shimoda,N. V. Iyer et al., "Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1," The Journal of Clinical Investigation, vol. 103, no. 5, pp. 691-696, 1999
71. L. A. Shimoda, D. J. Manalo, J. S. K. Sham, G. L. Semenza, and J. T. Sylvester, "Partial HIF-1 deficiency impairs pulmonary arterialmyocyte electrophysiological responses to hypoxia,"The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 281, no. 1, pp. L202-L208, 2001
72. J.-C. Roux, H. Brismar, A. Aperia, and H. Lagercrantz, "Developmental changes in HIF transcription factor in carotid body: relevance for O2 sensing by chemoreceptors," Pediatric Research, vol. 58, no. 1, pp. 53-57, 2005
73. D. D. Kline, Y.-J. Peng, D. J. Manalo, G. L. Semenza, and N. R. Prabhakar, "Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 821-826, 2002
74. Y.-J. Peng, J. Nanduri, S. A. Khan et al., "Hypoxia-inducible factor 2 (HIF-2) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 7, pp. 3065-3070, 2011
75. G. Yuan, Y.-J. Peng, V. D. Reddy et al., "Mutual antagonism between hypoxia-inducible factors 1 and 2 regulates oxygen sensing and cardio-respiratory homeostasis," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 19, pp. E1788-E1796, 2013
76. E. Schipani,H. E. Ryan, S. Didrickson, T. Kobayashi,M. Knight, and R. S. Johnson, "Hypoxia in cartilage: HIF-1 is essential for chondrocyte growth arrest and survival," Genes&Development, vol. 15, no. 21, pp. 2865-2876, 2001
77. O. Genbacev,Y. Zhou, J. W. Ludlow, and S. J. Fisher, "Regulation of human placental development by oxygen tension," Science, vol. 277, no. 5332, pp. 1669-1672, 1997
78. D. M. Adelman, M. Gertsenstein, A. Nagy, M. C. Simon, and E. Maltepe, "Placental cell fates are regulated in vivo by HIFmediated hypoxia responses," Genes and Development, vol. 14, no. 24, pp. 3191-3203, 2000
79. E. Maltepe, G. W. Krampitz, K. M. Okazaki et al., "Hypoxiainducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta," Development, vol. 132, no. 15, pp. 3393-3403, 2005
80. I. Caniggia, H. Mostachfi, J. Winter et al., "Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF3," Journal of Clinical Investigation, vol. 105, no. 5, pp. 577-587, 2000
81. A. Scheid, R. H. Wenger, L. Schäffer et al., "Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3," The FASEB Journal, vol. 16, no. 3, pp. 411-413, 2002
82. E. B. Rankin, A. J. Giaccia, and E. Schipani, "A central role for hypoxic signaling in cartilage, bone, and hematopoiesis," Current Osteoporosis Reports, vol. 9, no. 2, pp. 46-52, 2011
83. E. Duval, S. Leclercq, J.-M. Elissalde, M. Demoor, P. Galéra, and K. Boumédiene, "Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes," Arthritis and Rheumatism, vol. 60, no. 10, pp. 3038-3048, 2009
84. J. Bohensky, I. M. Shapiro, S. Leshinsky, S. P. Terkhorn, C. S. Adams, and V. Srinivas, "HIF-1 regulation of chondrocyte apoptosis: induction of the autophagic pathway," Autophagy, vol. 3, no. 3, pp. 207-214, 2007
85. T. Saito, A. Fukai, A. Mabuchi et al., "Transcriptional regulation of endochondral ossification by HIF-2 during skeletal growth and osteoarthritis development," Nature Medicine, vol. 16, no. 6, pp. 678-686, 2010
86. S. Yang, J. Kim, J. H. Ryu et al., "Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction," Nature Medicine, vol. 16, no. 6, pp. 687-693, 2010
87. I. Papandreou, R. A. Cairns, L. Fontana, A. L. Lim, and N. C. Denko, "HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption," Cell Metabolism, vol. 3, no. 3, pp. 187-197, 2006
88. T. Tsukihara, H. Aoyama, E. Yamashita et al., "The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2. 8 A," Science, vol. 272, no. 5265, pp. 1136-1144, 1996
89. L. G. J. Nijtmans, J.-W. Taanman, A. O. Muijsers, D. Speijer, and C. van den Bogert, "Assembly of cytochrome-c oxidase in cultured human cells," European Journal of Biochemistry, vol. 254, no. 2, pp. 389-394, 1998
90. J. Napiwotzki and B. Kadenbach, "Extramitochondrial ATP/ADP-ratios regulate cytochrome c oxidase activity via binding to the cytosolic domain of subunit IV," Biological Chemistry, vol. 379, no. 3, pp. 335-339, 1998
91. H. Zhang, M. Bosch-Marce, L. A. Shimoda et al., "Mitochondrial autophagy is an HIF-1-dependent adaptivemetabolic response to hypoxia," Journal of Biological Chemistry, vol. 283, no. 16, pp. 10892-10903, 2008
92. R. A. Menzies and P. H. Gold, "The turnover of mitochondria in a variety of tissues of young adult and aged rats," The Journal of Biological Chemistry, vol. 246, no. 8, pp. 2425-2429, 1971
93. B. Levine and D. J. Klionsky, "Development by self-digestion: molecular mechanisms and biological functions of autophagy," Developmental Cell, vol. 6, no. 4, pp. 463-477, 2004
94. M. Kundu and C. B. Thompson, "Macroautophagy versus mitochondrial autophagy: a question of fate" Cell Death & Differentiation, vol. 12, supplement 2, pp. 1484-1489, 2005
95. C. de Duve and R. Wattiaux, "Functions of lysosomes," Annual Review of Physiology, vol. 28, pp. 435-492, 1966
96. H. Zhu, P. Tannous, J. L. Johnstone et al., "Cardiac autophagy is a maladaptive response to hemodynamic stress," The Journal of Clinical Investigation, vol. 117, no. 7, pp. 1782-1793, 2007
97. R. S. Decker and K. Wildenthal, "Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes," The American Journal of Pathology, vol. 98, no. 2, pp. 425-444, 1980
98. A. Hamacher-Brady, N. R. Brady, S. E. Logue et al., "Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy," Cell Death & Differentiation, vol. 14, no. 1, pp. 146-157, 2007
99. R. K. Bruick, "Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9082-9087, 2000
100. D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, and G. L. Semenza, "Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2," Cancer Research, vol. 59, no. 16, pp. 3915-3918, 1999
101. M. C. Maiuri, G. Le Toumelin, A. Criollo et al., "Functional and physical interaction between Bcl-X and a BH3-like domain in Beclin-1," The EMBO Journal, vol. 26, no. 10, pp. 2527-2539, 2007
102. P. C. Fernandez, S. R. Frank, L. Wang et al., "Genomic targets of the human c-Myc protein," Genes and Development, vol. 17, no. 9, pp. 1115-1129, 2003
103. Z. Li, S. van Calcar, C. Qu, W. K. Cavenee, M. Q. Zhang, and B. Ren, "A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8164-8169, 2003
104. H. Zhang, P. Gao, R. Fukuda et al., "HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity," Cancer Cell, vol. 11, no. 5, pp. 407-420, 2007
105. J. D. Gordan, C. B. Thompson, and M. C. Simon, "HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation," Cancer Cell, vol. 12, no. 2, pp. 108-113, 2007
106. C. V. Dang, J.-W. Kim, P. Gao, and J. Yustein, "The interplay between MYC and HIF in cancer," Nature Reviews Cancer, vol. 8, no. 1, pp. 51-56, 2008
107. P. Carmeliet, Y. Dor, J. M. Herbert et al., "Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis," Nature, vol. 394, pp. 485-490, 1998
108. N. Akakura, M. Kobayashi, I. Horiuchi et al., "Constitutive expression of hypoxia-inducible factor-l renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation," Cancer Research, vol. 61, no. 17, pp. 6548-6554, 2001
109. M. T. Santore, D. S. McClintock, V. Y. Lee, G. R. S. Budinger, and N. S. Chandel, "Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 282, no. 4, pp. L727-L734, 2002
110. D. S. McClintock, M. T. Santore, V. Y. Lee et al., "Bc1-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death,"Molecular and Cellular Biology, vol. 22, no. 1, pp. 94-104, 2002
111. P. Saikumar, Z. Dong, Y. Patel et al., "Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury," Oncogene, vol. 17, no. 26, pp. 3401-3415, 1998
112. M. C. Wei,W. X. Zong, E. H. Y. Cheng et al., "ProapoptoticBAX and BAK: a requisite gateway to mitochondrial dysfunction and death," Science, vol. 292, no. 5517, pp. 727-730, 2001
113. S. Shimizu, Y. Eguchi, H. Kosaka,W. Kamiike, H. Matsuda, and Y. Tsujimoto, "Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL," Nature, vol. 374, no. 6525, pp. 811-813, 1995
114. T. G. Graeber, C. Osmanian, T. Jacks et al., "Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours," Nature, vol. 379, pp. 88-91, 1996
115. N. Morishima, K. Nakanishi, H. Takenouchi, T. Shibata, and Y. Yasuhiko, "An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome -independent activation of caspase-9 by caspase-12," The Journal of Biological Chemistry, vol. 277, no. 37, pp. 34287-34294, 2002
116. S. Basu and R. Kolesnick, "Stress signals for apoptosis: ceramide and c-Jun kinase," Oncogene, vol. 17, no. 25, pp. 3277-3285, 1998
117. A. Giatromanolaki, E. Sivridis, C. Kouskoukis, K. C. Gatter, A. L. Harris, and M. I. Koukourakis, "Hypoxia-inducible factors 1 and 2 are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin," Melanoma Research, vol. 13,no. 5, pp. 493-501,2003
118. S. C. Hanna, B. Krishnan, S. T. Bailey et al., "HIF1 and HIF2 independently activate SRC to promote melanoma metastases," Journal of Clinical Investigation, vol. 123, no. 5, pp. 2078-2093, 2013
119. V. Barak, J. Pe'er, I. Kalickman, and S. Frenkel, "VEGF as a biomarker for metastatic uveal melanoma in humans," Current Eye Research, vol. 36, no. 4, pp. 386-390, 2011
120. A. Giatromanolaki, E. Sivridis, C. Simopoulos et al., "Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas," Journal of Surgical Oncology, vol. 94, no. 3, pp. 242-247, 2006
121. M. Baba, S. Hirai, H. Yamada-Okabe et al., "Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factor," Oncogene, vol. 22, no. 18, pp. 2728-2738, 2003
122. M. Koshiji, Y. Kageyama, E. A. Pete, I. Horikawa, J. C. Barrett, and L. E. Huang, "HIF-1 induces cell cycle arrest by functionally counteracting Myc," The EMBO Journal, vol. 23, no. 9, pp. 1949-1956, 2004
123. R. A. Kauppinen and S. R. Williams, "Cerebral energy metabolism and intracellular pH during severe hypoxia and recovery: a study using 1H, 31P, and 1H [13C] nuclear magnetic resonance spectroscopy in the guinea pig cerebral cortex in vitro," Journal of Neuroscience Research, vol. 26, no. 3, pp. 356-369, 1990
124. M. V. Cutaia,N. Parks, J. Centracchio, S. Rounds,K. P. Yip, and A. M. Sun, "Effect of hypoxic exposure on Na+/H+ antiport activity, isoform expression, and localization in endothelial cells," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 275, no. 3, pp. L442-L451, 1998
125. L. K. Putney, S. P. Denker, and D. L. Barber, "The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions," Annual Review of Pharmacology and Toxicology, vol. 42, pp. 527-552, 2002
126. D. A. Quinn, C. G. W. Dahlberg, J. P. Bonventre et al., "The role of Na+/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation," The American Journal of Respiratory Cell and Molecular Biology, vol. 14, no. 2, pp. 139-145, 1996
127. R. M. Leach, D. W. Sheehan, V. P. Chacko, and J. T. Sylvester, "Effects of hypoxia on energy state and pH in resting pulmonary and femoral arterial smooth muscles," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 275, no. 6, pp. L1051-L1060, 1998
128. R. M. Leach, D. W. Sheehan, V. P. Chacko, and J. T. Sylvester, "Energy state, pH, and vasomotor tone during hypoxia in precontracted pulmonary and femoral arteries," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 2, pp. L294-L304, 2000
129. E. J. Rios, M. Fallon, J. Wang, and L. A. Shimoda, "Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smoothmuscle cells," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 289, no. 5, pp. L867-L874, 2005
130. L. A. Shimoda, M. Fallon, S. Pisarcik, J. Wang, and G. L. Semenza, "HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 291, no. 5, pp. L941-L949, 2006
131. H.-Y. Sun, N.-P. Wang, M. E. Halkos et al., "Involvement of Na+/H+ exchanger in hypoxia/re-oxygenation-induced neonatal rat cardiomyocyte apoptosis," European Journal of Pharmacology, vol. 486, no. 2, pp. 121-131, 2004
132. M. Stubbs, P. M. J. McSheehy, J. R. Griffiths, and C. L. Bashford, "Causes and consequences of tumour acidity and implications for treatment,"MolecularMedicine Today, vol. 6, no. 1, pp. 15-19, 2000
133. D. Fukumura, L. Xu, Y. Chen, T. Gohongi, B. Seed, and R. K. Jain, "Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo," Cancer Research, vol. 61, no. 16, pp. 6020-6024, 2001
134. E. Svastová, A. Hulíková, M. Rafajová et al., "Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH," FEBS Letters, vol. 577, no. 3, pp. 439-445, 2004
135. J. Chiche, K. Ilc, J. Laferrière et al., "Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH," Cancer Research, vol. 69, no. 1, pp. 358-368, 2009
136. M. E. Lindholm, H. Fischer, L. Poellinger et al., "Negative regulation of HIF in skeletal muscle of elite endurance athletes: a tentative mechanism promoting oxidative metabolism," The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 307, no. 3, pp. R248-R255, 2014
137. J. O. Holloszy and F. W. Booth, "Biochemical adaptations to endurance exercise inmuscle,"Annual Reviewof Physiology, vol. 38, pp. 273-291, 1976
138. M. J. N. McDonagh and C. T. M. Davies, "Adaptive response of mammalian skeletal muscle to exercise with high loads," European Journal of Applied Physiology and Occupational Physiology, vol. 52, no. 2, pp. 139-155, 1984
139. M. Kon, N. Ohiwa, A. Honda et al., "Effects of systemic hypoxia on humanmuscular adaptations to resistance exercise training," Physiological Reports, vol. 2, no. 6,Article ID e12033, 2014
140. V. I. Bushuev, G. Y. Miasnikova, A. I. Sergueeva et al., "Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia," Haematologica, vol. 91, no. 6, pp. 744-749, 2006
141. S. O. Ang, H. Chen, K. Hirota et al., "Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia," Nature Genetics, vol. 32, no. 4, pp. 614-621, 2002
142. F. Formenti, D. Constantin-Teodosiu, Y. Emmanuel et al., "Regulation of human metabolism by hypoxia-inducible factor," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12722-12727, 2010
143. M. A. Creager, J. W. Olin, J. J. F. Belch et al., "Effect of hypoxiainducible factor-1 gene therapy on walking performance in patients with intermittent claudication," Circulation, vol. 124, no. 16, pp. 1765-1773, 2011
144. C. M. R. leMoine, A. J. Morash, and G. B. McClelland, "Changes in HIF-1 protein, pyruvate dehydrogenase phosphorylation, and activity with exercise in acute and chronic hypoxia," American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 301, no. 4, pp. R1098-R1104, 2011
145. R. Mounier, V. Pialoux, B. Roels et al., "Effect of intermittent hypoxic training on HIF gene expression in human skeletal muscle and leukocytes," European Journal of Applied Physiology, vol. 105, no. 4, pp. 515-524, 2009
146. H. Niemi, K. Honkonen, P. Korpisalo et al., "HIF-1alpha and HIF-2alpha induce angiogenesis and improve muscle energy recovery," European Journal of Clinical Investigation, vol. 44, no. 10, pp. 989-999, 2014
147. T. Drevytska, B. Gavenauskas, S. Drozdovska, V. Nosar, V. Dosenko, and I. Mankovska, "HIF-3 mRNA expression changes in different tissues and their role in adaptation to intermittent hypoxia and physical exercise," Pathophysiology, vol. 19, no. 3, pp. 205-214, 2012.